Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Assets Average (2016 - 2025)

Historic Assets Average for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to $702.7 million.

  • Myriad Genetics' Assets Average fell 3512.74% to $702.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $702.7 million, marking a year-over-year decrease of 3512.74%. This contributed to the annual value of $1.1 billion for FY2024, which is 729.58% down from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Assets Average is $702.7 million, which was down 3512.74% from $841.7 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Assets Average high stood at $1.4 billion for Q1 2021, and its period low was $702.7 million during Q3 2025.
  • For the 5-year period, Myriad Genetics' Assets Average averaged around $1.2 billion, with its median value being $1.2 billion (2023).
  • Per our database at Business Quant, Myriad Genetics' Assets Average crashed by 354.64% in 2023 and then plummeted by 3512.74% in 2025.
  • Myriad Genetics' Assets Average (Quarter) stood at $1.3 billion in 2021, then decreased by 9.26% to $1.2 billion in 2022, then dropped by 4.77% to $1.1 billion in 2023, then decreased by 8.13% to $1.1 billion in 2024, then crashed by 33.36% to $702.7 million in 2025.
  • Its Assets Average stands at $702.7 million for Q3 2025, versus $841.7 million for Q2 2025 and $1.0 billion for Q1 2025.